Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6752
Rank
$0.63 B
Marketcap
$31.89
Share price
-0.08%
Change (1 day)
-0.35%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : $46.96 Million USD

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are $46.96 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$42.26 M8.17%
2023-12-31$39.07 M